Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes with Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients with Chronic Lymphocytic Leukemia from Senegal

Abibatou Sall, MDPhD, Teresa Amato, MB, PhD, Alessandro Gozzetti, Awa Oumar Touré, MD PhD, Saliou Diop, MD MSc, Lorenzo Leoncini, Pier Paolo Piccaluga, MD PhD, Martine Raphaël, MD PhD

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-138827

Published: 2020

Journal Articles

Using Smudge Cells Percentage on Routine Blood Smear in Chronic Lymphoytic Leukemia As Prognostic Factor: Senegalese Experience

Abibatou Sall, MD, Awa Oumar Touré, MD PhD, Fatimata Bintou Sall, MD, Abdoulaye Sène, PharmD, Cedric Aumont, PharmD, Moussa Seck, MD, Blaise Félix Faye, MD, Tandakha Ndiaye Dièye, PharmD, PhD, Saliou Diop, MD MSC, Sophie Reynaud, MD PhD, Martine Raphaël, MD PhD

Blood (2015) 126 (23): 5273.

https://doi.org/10.1182/blood.V126.23.5273.5273

Published: 2015

Journal Articles

Characteristics and Outcome Among 116 Patients with HIV Associated Lymphoma Included in the French ANRS CO16 Lymphovir Cohort Study.

Caroline Besson, Sophie Prevot, Houria Chavez, Selma Trabelsi, Michele Genin, Patricia Rince, Marie-Caroline Meyohas, Bruno Marchou, Jean Gabarre, Fabrice Bonnet, Cecile Goujard, Francois Boue, MD, PhD, Francois Raffi, Maria Partisani, Nicolas Mounier, MD, PhD, Yassine Taoufik, Martine Raphael, MD, PhD, Dominique Costagliola

Blood (2012) 120 (21): 2147.

https://doi.org/10.1182/blood.V120.21.2147.2147

Published: 2012

Journal Articles

Sequential Treatment with Rituximab Followed by CHOP Chemotherapy in Adult B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) - Establishing a New Standard of Care: Final Results From the Prospective International Multicenter PTLD-1 Trial

Ralf Trappe, MD, PhD, Stephan H.K. Oertel, MD, Veronique Leblond, MD, PhD, Peter Mollee, MBBS, MMedSc, Monica Sender, MD, Petra Reinke, MD, PhD, Ruth Neuhaus, MD, Hans Lehmkuhl, MD, PhD, Heinz A. Horst, MD, Gilles Andre Salles, MD, PhD, Franck Morschhauser, Arnaud Jaccard, MD, PhD, Thierry Lamy, MD, PhD, Malte Leithäuser, MD, Ioannis Anagnostopoulos, MD, PhD, Martine Raphael, MD, PhD, Hanno Riess, MD, PhD, Sylvain Choquet, MD

Blood (2011) 118 (21): 878.

https://doi.org/10.1182/blood.V118.21.878.878

Published: 2011

Journal Articles

Whole Blood Impedance Aggregometry: A New Tool for Severe Inherited Platelet Disorder Diagnosis?

Celine Desconclois, Vincent Valarche, Tewfik Boutekedjiret, Martine Raphael, MD, PhD, Marie Dreyfus, Valerie Proulle, MD, PhD

Blood (2011) 118 (21): 5266.

https://doi.org/10.1182/blood.V118.21.5266.5266

Published: 2011

Journal Articles

High Frequency of Marginal Zone Lymphomas Among Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus - ANRS CO16 LYMPHOVIR Cohort Study

Benjamin Terrier, Dominique Costagliola, Houria Chavez, Danielle Canioni, MD, Régis Costello, Lilia Escaut, Bertrand Joly, Lorraine Le Tranchant, Pascale Morineau-Le Houssine, Anne Simon, Yassine Taoufik, Sophie Prevot, Patrice Cacoub, Martine Raphael, MD, PhD, Caroline Besson

Blood (2010) 116 (21): 4156.

https://doi.org/10.1182/blood.V116.21.4156.4156

Published: 2010

Journal Articles

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

Blood (2009) 114 (22): 100.

https://doi.org/10.1182/blood.V114.22.100.100

Published: 2009

Journal Articles

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - A New Standard in Therapy?.

Ralf Trappe, MD, Sylvain Choquet, MD, Stephan Oertel, MD, Veronique LeBlond, MD, Tor Ekman, MD, Monica Sender, MD, Peter Molle, MD, Petra Reinke, MD, Hans Lehmkuhl, MD, Manfred Hummel, MD, Sven Jonas, MD, Ruth Neuhaus, MD, Gilles Salles, MD, Franck Morschhauser, MD, Arnaud Jaccard, MD, Daan Dierickx, MD, Ionannis Anagnostopoulos, MD, Martine Raphael, MD, Hanno Riess, MD

Blood (2007) 110 (11): 390.

https://doi.org/10.1182/blood.V110.11.390.390

Published: 2007

Journal Articles

Epstein-Barr Virus: Main Pathogenic Agent in Hodgkin Lymphoma Associated Hemophagocytic Syndrome?.

Fanny Menard, PharmD, Caroline Besson, MD, PhD, Patricia Rince, Olivier Lambotte, MD, PhD, Thierry Lazure, MD, Danielle Canioni, MD, Olivier Hermine, MD, PhD, Pierre Brousset, MD, PhD, Claire Legendre, MD, Antoine Martin, MD, Philippe Gaulard, MD, PhD, Martine Raphael, MD, PhD, Claire Larroche, MD

Blood (2007) 110 (11): 2272.

https://doi.org/10.1182/blood.V110.11.2272.2272

Published: 2007

Journal Articles

Long Term Efficacy of Rituximab in B-Cell Post Transplantation Lymphoproliferative Disorders (B-PTLD): Update of the Multicenter, Open Label, Phase II Trial (M39037 TRIAL).

Sylvain Choquet, MD, Raoul Herbrecht, MD, Anne-marie Stoppa, MD, Peter Vandenberghe, MD, Walter Feremans, MD, Franck Morschhauser, MD, Gilles Andre Salles, MD, Arnaud Jaccard, MD, Thierry Lamy, MD, Yves Lebranchu, MD, Philippe Offner, MD, Eric Oksenhendler, MD, Martine Raphael, MD, Veronique Leblond, MD, Noel-Jean Milpied, MD

Blood (2006) 108 (11): 2764.

https://doi.org/10.1182/blood.V108.11.2764.2764

Published: 2006

Journal Articles

Prevention of Post Transplantation Lymphoproliferative Disorders by Adapted Management of EBV Reactivations. A Monocentric Prospective Study on 101 Patients.

Sylvain Choquet, MD, Shaida Varnous, md, Claire Deback, md, Corinne Amiel, md, Jean Louis Golmar, Iradj Gandjbackhch, md, Martine Raphael, md, Veronique Leblond, md

Blood (2006) 108 (11): 2932.

https://doi.org/10.1182/blood.V108.11.2932.2932

Published: 2006

Journal Articles

Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).

Jacques Vargaftig, MD, Brigitte Pegourié-Bandelier, MD, Béatrice Mahé, MD, Steven Le Gouill, MD, PhD, Elisabeth Brottier-Mancini, MD, Richard Delarue, MD, Agnès Buzyn, MD, PhD, Martine Raphael, MD, Sylvain Choquet, MD, Véronique Leblond, MD

Blood (2006) 108 (11): 4727.

https://doi.org/10.1182/blood.V108.11.4727.4727

Published: 2006

Journal Articles

Primary Central Nervous System Lymphomas (PCNSL) Are Distinct from Systemic DLBCL for Expression Pattern of Germinal Center and Activation B-Cell Markers. A GOELAMS Study.

Sophie Camilleri-Broet, MD, PhD, Vincent Delwail, MD, Anne Moreau, MD, Martine Gardembas, MD, Martine Raphael, MD, PhD, Thierry Lamy, MD, Catherine Sautes-Fridman, PhD, Philippe Colombat, MD, Antoine Martin, MD

Blood (2004) 104 (11): 2264.

https://doi.org/10.1182/blood.V104.11.2264.2264

Published: 2004

NARROW

Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes with Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients with Chronic Lymphocytic Leukemia from Senegal

Using Smudge Cells Percentage on Routine Blood Smear in Chronic Lymphoytic Leukemia As Prognostic Factor: Senegalese Experience

Characteristics and Outcome Among 116 Patients with HIV Associated Lymphoma Included in the French ANRS CO16 Lymphovir Cohort Study.

Sequential Treatment with Rituximab Followed by CHOP Chemotherapy in Adult B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) - Establishing a New Standard of Care: Final Results From the Prospective International Multicenter PTLD-1 Trial

Whole Blood Impedance Aggregometry: A New Tool for Severe Inherited Platelet Disorder Diagnosis?

High Frequency of Marginal Zone Lymphomas Among Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus - ANRS CO16 LYMPHOVIR Cohort Study

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - A New Standard in Therapy?.

Epstein-Barr Virus: Main Pathogenic Agent in Hodgkin Lymphoma Associated Hemophagocytic Syndrome?.

Long Term Efficacy of Rituximab in B-Cell Post Transplantation Lymphoproliferative Disorders (B-PTLD): Update of the Multicenter, Open Label, Phase II Trial (M39037 TRIAL).

Prevention of Post Transplantation Lymphoproliferative Disorders by Adapted Management of EBV Reactivations. A Monocentric Prospective Study on 101 Patients.

Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).

Primary Central Nervous System Lymphomas (PCNSL) Are Distinct from Systemic DLBCL for Expression Pattern of Germinal Center and Activation B-Cell Markers. A GOELAMS Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only